FilingSEC EDGAR8-K
Acumen Pharmaceuticals Hosts Investor Day and Shares Pipeline Strategy
· SEC accepted
StagePresentation
Filing content
The company hosted an Investor Day to present the clinical status of its Alzheimer's candidate, sabirnetug, and its future development strategy.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…